FDA Drug · D-0287-2025

PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-30

Class II · Ongoing

Failed Dissolution Specifications

Affected lots / codes — check yours against thisLot no's: GS059908, GS060228, GS060709, GS061233, GS061704, GS062158, GS062405, Exp.: 04/30/2026

Recalling firm: Golden State Medical Supply Inc., Camarillo, CA
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 2,601 30-count bottles
Distribution: U.S. Nationwide
Recall initiated: March 5, 2025
Classified: March 20, 2025
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0287-2025%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →